et al. Phase I study of pemetrexed and pegylated liposomal doxorubicin in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer. Invest New Drugs 29, 963–970 (2011). https://doi.org/10.1007/s10637-010-9414-6 Download citation Received26 January 2010 Accepted01...